Approval · Notice of Compliance 5041 · 1995
HAVRIX: Notice of Compliance 5041
Issued October 16, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5041
- Date
- October 16, 1995
- Company
- Smithkline Beecham Pharma, Inc.Gronau, Saone Et Loire, Germany
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage regimen, new strength
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HAVRIX | 02187078 | Marketed |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 1,440 UNIT per ML